| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8439498 | European Journal of Cancer | 2018 | 9 Pages |
Abstract
In this analysis, we found that risk factors were most strongly associated enrolment in the IDEAL trial. In contrast, patient experiences were the most significant factors leading to early treatment discontinuation, with no effect on DFS.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Erik J. Blok, Judith R. Kroep, Elma Meershoek-Klein Kranenbarg, Marjolijn Duijm-de Carpentier, Hein Putter, Gerrit-Jan Liefers, Johan W.R. Nortier, Emiel J.Th. Rutgers, Caroline M. Seynaeve, Cornelis J.H. van de Velde,